TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

Martin J van den Bent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.